Canaccord Genuity Reiterates Buy Rating on WAVE Life Sciences (WVE)

August 20, 2025 6:46 AM EDT Send to a Friend
Canaccord Genuity analyst Whitney Ijem reiterated a Buy rating and $19.00 price target on WAVE Life Sciences (NASDAQ: WVE).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login